Page last updated: 2024-08-23

thymopentin and Scleroderma, Systemic

thymopentin has been researched along with Scleroderma, Systemic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calisi, L; Danese, C; Marcianò, F; Perego, MA; Zavattaro, E1
Bertelletti, D; Biasi, G; Giordano, N; Marcolongo, R; Morozzi, G; Vaccai, D1
Bertelletti, D; Biasi, G; Giordano, N; Marcolongo, R; Taddeo, A1

Trials

1 trial(s) available for thymopentin and Scleroderma, Systemic

ArticleYear
[Evaluation of the use of thymopentin in patients with progressive systemic sclerosis].
    La Clinica terapeutica, 1991, Mar-31, Volume: 136, Issue:6

    Topics: Female; Humans; Male; Middle Aged; Scleroderma, Systemic; Thymopentin; Time Factors

1991

Other Studies

2 other study(ies) available for thymopentin and Scleroderma, Systemic

ArticleYear
Long-term thymopentin treatment in systemic scleroderma.
    Current medical research and opinion, 1994, Volume: 13, Issue:4

    Topics: Adult; Aged; Antibodies, Antinuclear; Female; Humans; Lymphocyte Subsets; Male; Middle Aged; Scleroderma, Systemic; Thymopentin

1994
An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
    Clinical rheumatology, 1989, Volume: 8, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Aged; Female; Humans; Middle Aged; Peptide Fragments; Scleroderma, Systemic; Thymopentin; Thymopoietins; Thymus Hormones

1989
chemdatabank.com